Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
“Miracle on the Hudson” Pilot Sully Sullenberger Diagnosed with Alzheimer’s
A Glimpse of the Future from the Alzheimer’s Association International Conference
Next-Generation Alzheimer’s Drugs Show Mixed Results at AAIC
How Well Do Alzheimer’s Blood Tests Work in the Real World?
FDA Approves At-Home Injectable Leqembi for Early Alzheimer’s
THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s
How Artificial Intelligence Could Accelerate Alzheimer’s Diagnosis and Discoveries
Understanding and Detecting LATE, a Common Form of Dementia
Unraveling the Links Between Soccer and Brain Injury
Next-Generation Alzheimer’s Drugs, Blood Tests and Prevention Research Take Center Stage at AAIC
Fish Oil Supplements Failed to Prevent or Slow Cognitive Decline in Trial
Beyond the Blood Tests: Why Amyloid PET Remains the Gold Standard
Lethal Weapon Star Danny Glover Reveals Alzheimer’s Diagnosis
An AI Model Could Change How We Prevent Alzheimer’s
Huntington’s Gene Therapy Back on Track to File for FDA Approval
1
2
Next
Page load link
Go to Top